Eden Research (LON:EDEN) Shares Down 0.2% – What’s Next?

Eden Research plc (LON:EDEN)’s stock price fell 0.2% on Friday . The stock traded as low as GBX 3.59 ($0.05) and last traded at GBX 3.59 ($0.05). 10,000 shares traded hands during trading, a decline of 99% from the average session volume of 920,772 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The business has a 50-day moving average of GBX 3.88 and a 200-day moving average of GBX 3.95. The company has a market capitalization of £19.17 million, a P/E ratio of -12.59 and a beta of 0.92.

Insider Transactions at Eden Research

In other Eden Research news, insider Alexander John Abrey acquired 540,540 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were bought at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,396.86). Also, insider Lykele van der Broek bought 256,000 shares of Eden Research stock in a transaction on Thursday, February 6th. The stock was acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,975.16). Company insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.